The Brand Called You A Chat with Dr. Xiling Shen, Prof & Chief Scientific Officer, Terasaki Inst for Biomedical Innovation
Dec 1, 2022
57:52
Cancer is understandably a dreaded disease, and late diagnosis often leads to heart-wrenching results of loss. Early diagnosis and the right course of treatment are essential to get life back on track. And if professionals are not well-equipped or educated about the kinds of cancers that exist, they can be life-threatening for the patients.
Today, we have Dr. Xiling Shen, Prof & Chief Scientific Officer, Terasaki Inst for Biomedical Innovation to talk to us about the technology to cure cancer.
About Dr. Xiling Shen
- Dr. Xiling Shen: Professor and the Chief Scientific Officer of the Terasaki Institute for Biomedical Innovation; Entrepreneur.
- He is the founder and Chief Executive Officer of Xilis Inc.
- He was previously director of Woo Center for Big Data and Precision Health at Duke University, steering committee chair of the NCI Patient-Derived Model of Cancer Consortium, and chair of the NCI Patient-Derived Model of Cancer Consortium.
- He is the co-chair of the NCI Tissue Engineering Consortium, and cancer track and chair of the Biomedical Engineering Society 2019.
- Dr. Shen's lab specializes in precision medicine and systems biology.
- His members integrate biological engineering, and computational techniques to study cancer, stem cells, and the gut-brain axis.